Home

Curis, Inc. - Common Stock (CRIS)

1.1600
-0.0700 (-5.69%)
NASDAQ · Last Trade: Apr 8th, 1:42 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · April 2, 2025
Earnings Scheduled For March 31, 2025benzinga.com
Via Benzinga · March 31, 2025
Examining the Future: Curis's Earnings Outlookbenzinga.com
Via Benzinga · November 13, 2024
Earnings Scheduled For February 8, 2024benzinga.com
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
Via Benzinga · February 8, 2024
Curis's Earnings: A Previewbenzinga.com
Via Benzinga · February 7, 2024
Preview: Curis's Earningsbenzinga.com
Via Benzinga · November 1, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · January 2, 2025
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · June 10, 2024
CRIS Stock Earnings: Curis Beats EPS, Misses Revenue for Q1 2024investorplace.com
CRIS stock results show that Curis beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 7, 2024
Top 3 Health Care Stocks That May Collapse In Q2benzinga.com
As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Via Benzinga · April 12, 2024
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · April 4, 2024
Analyst Ratings for Curisbenzinga.com
Via Benzinga · September 25, 2023
Expert Ratings for Curisbenzinga.com
Via Benzinga · September 7, 2023
Earnings Scheduled For November 14, 2024benzinga.com
Via Benzinga · November 14, 2024
CyberArk Software To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Fridaybenzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via Benzinga · February 9, 2024
Why BlackBerry Shares Are Trading Lower By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Sessionbenzinga.com
Shares of BlackBerry Limited (NYSE: BB) fell sharply during Wednesday’s session after the company announced a proposed private offering of $160 million of convertible senior notes. BlackBerry shares tumbled 17.2% to $2.9387 on Wednesday.
Via Benzinga · January 24, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga.com
Via Benzinga · January 24, 2024
Why Genesco Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Sessionbenzinga.com
Gainers Harbor Custom Development, Inc. (NASDAQ: HCDI) rose 74.2% to $1.50 after surging 24% on Thursday.
Via Benzinga · December 1, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 29, 2023
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 22, 2023
Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Sessionbenzinga.com
Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance.
Via Benzinga · November 17, 2023
Vail Resorts, Carnival, Opera And Other Big Stocks Moving Lower On Fridaybenzinga.com
U.S. stocks traded higher, with the Nasdaq Composite gaining around 1% on Friday. Here are some big stocks recording losses in today’s session. Corcept Therapeutics Incorporated (NASDAQ: CORT) shares fell 21% to $26.07.
Via Benzinga · September 29, 2023
Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Sessionbenzinga.com
Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of fasedienol met the primary and secondary endpoints.
Via Benzinga · August 7, 2023
Analyst Holds Steady On Curis As FDA Removes Partial Clinical Hold On Leukemia Studybenzinga.com
Thursday, the FDA removed the partial clinical hold on Curis Inc's (NASDAQ: CRIS) TakeAim Leukemia Phase 1/2 study of emavusertib 
Via Benzinga · July 7, 2023
Meta Platforms To Rally Over 14%? Here Are 10 Other Analyst Forecasts For Fridaybenzinga.com
Needham raised the price target for Applied Digital Corporation (NASDAQ: APLD) from $8.5 to $16. Needham analyst John Todaro maintained a Buy rating. Applied Digital shares fell 14.2% to close at $7.70 on Thursday.
Via Benzinga · July 7, 2023